Palliative oncology and palliative care

Area of Science:

• Oncology
• Palliative Care
• Geriatric Medicine

Background:

• Novel cancer therapies are expanding treatment eligibility to severely ill patients, including the elderly and those with comorbidities.
• This shift necessitates advanced prognostication and careful consideration of treatment benefits versus burdens.

Purpose of the Study:

• To emphasize the critical need for early integration of specialist palliative care into cancer treatment plans.
• To explore how palliative care specialists navigate the complexities of novel treatments for vulnerable patient populations.
• To advocate for equitable access to palliative care and the avoidance of futile treatments.

Main Methods:

• Review of current challenges in cancer prognostication with new therapies.
• Discussion of the role of palliative care in symptom management and psychosocial support.
• Analysis of balancing novel treatment benefits against adverse effects in elderly and frail patients.

Main Results:

• Early integration of palliative care can prolong survival and enhance quality of life.
• Palliative care specialists are crucial in managing treatment-related toxicities and patient-reported outcomes.
• Avoiding burdensome treatments in frail, elderly patients is essential.

Conclusions:

• Integrating palliative care early is vital for optimizing cancer patient outcomes, focusing on quality of life and survival.
• Equitable access to palliative care and judicious treatment selection are paramount, especially for vulnerable populations.
• Further translational research is needed to bridge basic science with clinical oncology and symptom management.